Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2009 - 2025)

Updated

Kazia Therapeutics' Non-Current Deferred Tax Liability was $181,937 in fiscal Q2 2026 (quarter ended Dec 31, 2025).

Analysis

Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2009 - 2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Non-Current Deferred Tax Liability at Kazia Therapeutics came in at $177,461.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 181,937.10
Jun 30, 2025 177,461.07
Dec 31, 2009 -68,271.65
API Access

Kazia Therapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=KZIA&period=max&api_key=YOUR_API_KEY